An antiviral agent indicated in adults and children 1 year for the treatment of illness due to influenza and for prophylaxis following exposure to influenza type A viruses. It has no effect against the influenza type B virus.
an antiparkinsonian; prescribed to offset some side effects from psychoactive drugs; brand names include Symmetrel. Amantadine side effects.
A drug which stimulates the release of available dopamine in the brain.
A drug used to treat Parkinson's. See PDS publication The Drug Treatment of Parkinson's Disease (code B13) - 949kb pdf format
Initially developed as an antiviral agent, this drug improves mild tremor, rigidity, and bradykinesia in some patients with PD. The exact mechanism of action is unclear; however, it seems to increase release of dopamine from the remaining cells of the substantia nigra
a medication initially designed to relieve influenza symptoms but later found to assist with rigidity and other parkinsonian symptoms. May also help to reduce dyskinesias.
(Amantadine hydrochloride) Antiviral agent used to prevent or treat influenza; also used to treat Parkinson's disease.
Amantadine (1-aminoadamantane, sold as Symmetrel®) is an antiviral drug that was approved by the Food and Drug Administration in 1976 for the treatment of Influenzavirus A in adults. The drug has also been demonstrated to help reduce symptoms of Parkinson's disease and drug-induced extrapyramidal syndromes. As an antiparkinsonic it can be used as monotherapy; or together with L-DOPA to treat L-DOPA-related motor fluctuations (i.e., shortening of L-DOPA duration of clinical effect, probably related to progressive neuronal loss) and L-DOPA-related dyskinesias (choreiform movements associated with long-term L-DOPA use, probably related to chronic pulsatile stimulation of dopamine receptors).
